Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02553460
Title Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphoblastic leukemia

Therapies

Cyclophosphamide

Mitoxantrone

Dexamethasone

Bortezomib

Etoposide

Vincristine Sulfate

Pegaspargase

Vorinostat

Cytarabine

Methotrexate

Leucovorin

Age Groups: child
Covered Countries USA | CAN


No variant requirements are available.